The purpose of this Pre-approval access (PAA) program is to provide VAC31518 (Ad26.CoV2.S) vaccine for the prevention of coronavirus disease-2019 (COVID-19) infection.

This PAA program may be considered to protect participants against a serious/life-threatening diseases or conditions, where there are no alternative treatments available.